Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the tension of co... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the tension of co... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the amplitude of... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the frequency of... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the amplitude of... by Barbara Jana (9110179)

The 27 proteins which were significantly deregulated in glia treated with AD plasma, but not deregulated in either control or MCI plasma treated glia (shown in Table 4) were analys... by Tharusha Jayasena (704509)

Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis. by Swati Biswas (73661)

“…<p><b>Panel a:</b> Boxplot of number of TRAP positive osteoclasts per millimeter of bone surface in MBA-MB-231 tumor-bearing tibiae, showing significantly decreased osteoclasts upon 1D11 treatment, compared to 13C4. …”

Transcriptomic analysis of the long-lived and short-lived Atg1 over-expressing flies reveals decreased lipid metabolism. by Ivana Bjedov (75652)

AC5 performs the coincidence detection between G_olf and G_i. by Hidetoshi Urakubo (578508)

Subjects:

PSG-specific <i>Fzr</i> mutation decreases the expression of silk protein genes. by Wenliang Qian (639395)

“…(<b>B-D</b>) <i>Fzr</i> mutation in the PSG decreased the transcription of silk protein genes, including <i>FibH</i> (B), <i>FibL</i> (C), and <i>P25</i> (D). …”

Increased inflammation and decreased proliferation in DSS-treated<i>Mttp-IKO</i> mice. by Yan Xie (41714)

L-sel decreases the number of circulating lymphocytes. by Izabela Rozenberg (214521)

“…<p><i>ApoE</i>^{−<i>/</i>−}<i>L-sel</i>^{−<i>/</i>−} animals exhibit increased number of <b>A</b>) total blood lymphocytes (n = 5–8; ^*p<0.05), <b>B</b>) T-cytotoxic cells (CD8⁺; n = 6–7; ^**p<0.01, ^#p<0.05), <b>C</b>) B lymphocytes (CD19⁺; n = 5–7; ^*p<0.05, ^#p<0.05), <b>D</b>) total T-helper cells (CD4⁺; n = 6–7; ^#p<0.0), <b>E</b>) naive T-helper cells (CD4⁺CD44⁻; n = 5–7; ^*p<0.05; ^##p<0.0001) after 6 and 12 weeks of HCD, respectively. …”

mPEG PV1-Fab’ treatment decreases T_reg population. by Pedro Henrique Papotto (791904)

Decreased F4/80⁺ macrophages in the presence of PLD inhibitors using IF microscopy of lung sections. by Karen M. Henkels (3350273)

Subjects:

TCN and gemcitabine treatment decreases Akt activity and proliferation rate <i>in vivo</i>. by Junmei Hou (165648)

Decreased Ly6G⁺ neutrophils in the presence of PLD inhibitors using IF microscopy of lung sections. by Karen M. Henkels (3350273)

Subjects:

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Decreased mRNA levels of inflammatory cytokines from <i>cpdm</i> BMDC. by Zhe Wang (41178)

Atorvastatin decreases proliferation of breast cancer cells more potently than rosuvastatin. by Colin H. Beckwitt (2037196)